Enliven Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Enliven Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2020 to Q3 2024.
  • Enliven Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 48.9M shares, a 18.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 48.9M +7.65M +18.6% Nov 1, 2024 10-Q 2024-11-13
Q2 2024 47.2M +6.09M +14.8% Aug 1, 2024 10-Q 2024-08-13
Q1 2024 41.3M +233K +0.57% Mar 1, 2024 10-K 2024-03-14
Q3 2023 41.2M +14.9M +56.8% Nov 1, 2023 10-Q 2023-11-09
Q2 2023 41.2M +14.9M +56.5% Aug 1, 2023 10-Q 2023-08-10
Q1 2023 41.1M +14.8M +56.5% May 1, 2023 10-Q 2023-05-11
Q4 2022 26.2M Feb 6, 2023 10-K 2023-02-10
Q3 2022 26.3M +11.5K +0.04% Oct 20, 2022 10-Q 2022-10-25
Q2 2022 26.3M +40K +0.15% Aug 1, 2022 10-Q 2022-08-03
Q1 2022 26.3M +8.7M +49.5% Apr 30, 2022 10-Q 2022-05-06
Q3 2021 26.3M +8.87M +50.9% Oct 29, 2021 10-Q 2021-11-09
Q2 2021 26.2M +8.92M +51.5% Aug 2, 2021 10-Q 2021-08-06
Q1 2021 17.6M +295K +1.71% Mar 1, 2021 10-K 2021-03-05
Q3 2020 17.4M Oct 30, 2020 10-Q 2020-11-05
Q2 2020 17.3M Jul 31, 2020 10-Q 2020-08-14
Q1 2020 17.3M May 1, 2020 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.